Compare FSLY & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSLY | VCYT |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2019 | 2013 |
| Metric | FSLY | VCYT |
|---|---|---|
| Price | $23.19 | $41.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $18.00 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 4.8M | 1.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.19 | ★ 164.52 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $624,018,000.00 | N/A |
| Revenue This Year | $16.39 | $13.76 |
| Revenue Next Year | $10.73 | $12.35 |
| P/E Ratio | ★ N/A | $61.92 |
| Revenue Growth | ★ 14.78 | N/A |
| 52 Week Low | $7.74 | $29.46 |
| 52 Week High | $34.82 | $60.91 |
| Indicator | FSLY | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 49.53 | 39.93 |
| Support Level | $22.72 | $40.80 |
| Resistance Level | $25.36 | $42.98 |
| Average True Range (ATR) | 1.44 | 1.76 |
| MACD | -0.07 | 0.14 |
| Stochastic Oscillator | 54.73 | 11.02 |
Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).